Last reviewed · How we verify

NCT03944733: IDinteract

Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions

Withdrawn NA Last updated 20 November 2025
What this trial tests

NA trial testing Iron in Iron Deficiency Anemia. Withdrawn.

Timeline
1 December 2019
Primary endpoint
30 December 2020
30 December 2020

Quick facts

Lead sponsorPenn State University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingquadruple
Primary purposeother
Start date1 December 2019
Primary completion30 December 2020
Estimated completion30 December 2020

Drugs / interventions tested

Conditions studied

Sponsor

Penn State University

Who can join

Adults 18 to 40, female only, with Iron Deficiency Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the relation between iron status and maternal-child interactions as well as maternal depressive symptoms in mothers from central Pennsylvania.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Iron

Trials testing the same drug.

Other recruiting trials for Iron Deficiency Anemia

Currently open trials in the same condition.

Other Penn State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03944733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing